We determined MICs of antibiotics against Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Ehrlichia canis by real-time quantitative PCR. The doubling times of the organisms were established: 19 h for E. chaffeensis, 26 h for A. phagocytophilum, and 28 h for E. canis. In comparison to the reference method for determining sensitivities, which uses Diff-Quick staining, our PCR assay was very sensitive and specific. We confirmed that doxycycline and rifampin are highly active against these bacteria and found variable susceptibilities to fluoroquinolones; A. phagocytophilum was susceptible, but E. canis and E. chaffeensis were only partly susceptible. ␤-Lactam compounds, cotrimoxazole, macrolide compounds, and telithromycin showed no activity against any of the three organisms. Thiamphenicol was found to be more active than chloramphenicol. For the first time, we showed that these three species have numerous point mutations in their 23S RNA genes, with those at positions 754, 2057, 2058, 2059, and 2611 (Escherichia coli numbering) known to confer resistance to macrolide compounds in other bacteria. The role of each of these mutations in resistance to these drugs should be investigated in the future. Our study confirms previous reports that quantitative PCR is a reliable method for determining antibiotic susceptibility; therefore, it might be useful for screening new drugs.
americanum, and E. canis is transmitted by Rhipicephalus sanguineus. In their mammalian hosts, these small, nonmotile gram-negative bacteria live and grow in cytoplasmic vacuoles and form loose to condensed aggregates of bacteria termed morulae. The morulae of different species are found in different cells in their hosts; E. canis and E. chaffeensis morulae are found in monocytes and macrophages, while A. phagocytophilum infects neutrophils of humans and many animals (46) .
Tetracyclines are highly active in vitro against E. canis, E. chaffeensis, and A. phagocytophilum, and doxycycline is currently the first-line antibiotic in the treatment of patients infected with these organisms (13, 45) . Rifampin is active against Ehrlichia in vitro and may represent a safe alternative for patients who should not receive tetracycline, for example, pregnant women and children (9) . In vitro susceptibility to fluoroquinolones differs by species; A. phagocytophilum is susceptible while E. chaffeensis is resistant (7, 28, 33) . This difference in susceptibility to fluoroquinolones was recently related to a natural DNA gyrase-mediated resistance (32) .
In vitro tests currently used to assess the antibiotic susceptibilities of the organisms are based on microscopic counting of morulae in cells in tissue cultures before and after exposure to serial dilutions of antibiotics. These tests, however, are not standardized, are not sensitive, are time-consuming, and are not adapted for the screening of new drugs or strains of organisms. Recently, PCR and real-time quantitative PCR have been used successfully to study the antibiotic susceptibilities of other intracellular bacteria such as Rickettsia species (41) , Wolbachia pipientis (18) , Coxiella burnetii (3, 5) , and Tropheryma whipplei (4, 31) . These methods are simple, rapid, sensitive, reproducible, and specific and provide the possibility of automation. In this report, we describe the antibiotic susceptibilities of three reference strains of Ehrlichia and Anaplasma determined by real-time quantitative PCR with primers of the 16S ribosomal DNA (rDNA). We compare our findings with susceptibilities obtained by using the classical method in which morulae are counted microscopically. Furthermore, we aligned and compared the 23S rDNA sequences of these bacteria in order to seek a potential genetic correlation with resistance to macrolide compounds, which would be the subject of future investigation.
MATERIALS AND METHODS
Strains. Strains used in the study were E. canis strain Oklahoma, E. chaffeensis strain Arkansas, and A. phagocytophilum strain Webster (J. S. Dumler, The Johns Hopkins Medical Institutions, Baltimore, Md.). E. canis and E. chaffeensis were grown in a DH82 canine malignant histiocytic cell line (ATTC number CR5L-10389) (47) . Percentages of infected cells were monitored twice a week by Diff-Quick staining as previously described (7).
A. phagocytophilum was grown in the human promyelocytic cell line HL60 at 37°C under a 5% CO 2 atmosphere (20) . Three times a week, the percentage of infected cells was determined by counting cells with morulae in cytocentrifuged preparations stained with Diff-Quick. Concentrations of uninfected and infected cells were maintained at 4 ϫ 10 5 and 2 ϫ 10 5 /ml, respectively. Source and preparation of antibiotic solutions. Antibiotics and their concentration ranges used in this study were as follows: doxycycline, 0.03 to 4 g/ml (Pfizer, Neuilly, France); levofloxacin, 0.5 to 2 g/ml (Hoechst Marion Roussel, Romainville, France); ciprofloxacin, 0.5 to 2 g/ml (Bayer, Pharma, Sebs, France); ofloxacin, 0.5 to 2 g/ml (Diamant, Puteaux, France); erythromycin, 4 g/ml (Abbott, Rungis, France); telithromycin, 1 g/ml (Hoechst Marion Roussel); thiamphenicol, 0.5 to 4 g/ml (Sanofi, Winthrop, Gentilly, France); rifampin, 0.03 to 1 g/ml (Cassenne, Puteaux, France); cotrimoxazole (trimethoprim and sulfamethoxazole), 8 to 32 g/ml (Roche, Paris, France); gentamicin, 2.5 to 20 g/ml (Dakota Pharm, Creteil, France); amoxicillin, 10 to 100 g/ml (Beecham-Sevigne, Paris, France); ceftriaxone, 10 to 100 g/ml (Roche, Neuilly sur Seine, France). Stock solutions were prepared as described by the manufacturer and stored at Ϫ20°C. Final antibiotic solutions were made up by diluting concentrated stock solutions in a medium adapted to the bacteria.
Growth kinetics. Microplates (24-well plates; final volume, 1 ml) were inoculated with cell cultures, prepared as above, in which about 5% of cells contained morulae. HL60 cells were maintained at 2 ϫ 10 5 /ml. Percentages of infected cells were monitored daily over 5 days by removing 100 l from a well for cytocentrifugation, staining with Diff-Quick, and preserving the remaining 900 l at Ϫ20°C for real-time PCR.
Antimicrobial susceptibility testing. The growth curves were analyzed as described above to determine the optimal time for testing antibiotic susceptibilities of bacteria. This optimal time was defined as the number of days necessary to reach the plateau of the growth curve. Initially, antibiotics were tested at the MIC breakpoint for resistance as defined by the current NCCLS guidelines. If the bacteria were inhibited at this concentration, MICs were then determined by using twofold serial dilutions. The MIC was defined as the lowest antibiotic concentration required for inhibition of the growth of the bacteria compared to that of the control (without antibiotics) at day 0. An infected culture without antibiotics served as a positive growth control, and an uninfected cell culture served as a negative control. All experiments were performed in triplicate and repeated three times to confirm results. Wells were sampled each day, and samples were divided into aliquots and stored at Ϫ20°C until genomic DNA was extracted for PCR assays.
Antibiotic activity. The activities of the antibiotics were verified at the end of each experiment against two reference strains, Staphyloccocus aureus CIP 103429 and Escherichia coli CIP 76.24, as previously described (31, 39) .
LightCycler PCR assay. Total genomic DNA of each harvested well was extracted from aliquots by using a MaGNA Pure instrument as described by the manufacturer (Roche Diagnostics, Courtaboeuf, France). DNA was extracted from 100 l of cell culture, and a total of 100 l of elution buffer was used to resuspend the DNA. PCR was performed using a LightCycler instrument (Roche Biochemicals, Mannheim, Germany) to amplify a 345-bp fragment of the 16S rRNA of Ehrlichia or Anaplasma (35) Sequence-specific standard curves were generated by using 10-fold serial dilutions of an extracted DNA sample containing 100% infected cells of E. canis, E. chaffeensis, and A. phagocytophilum, respectively. The number of DNA copies of each sample transcript was then calculated from the standard curve with the LightCycler software. For each experiment, the mean number (Ϯ standard deviation) of DNA copies in cultures was determined at day 0 and compared to the mean number (Ϯ standard deviation) of DNA copies in antibiotic-treated cultures at day 4. Lack of bacterial inhibition was defined as a mean number of DNA copies at day 4 statistically higher than that at the start of the experiment (by the Student t test). The MIC was defined as the lowest antibiotic concentration allowing inhibition of bacterial growth, i.e., a number of DNA copies at day 4 not statistically different from that at day 0. The specificity of amplification was then confirmed by agarose gel electrophoresis of PCR products and DNA sequencing.
Study of 23S rRNA in A. phagocytophilum, E. chaffeensis, and Wolbachia pipientis. Sequences of the 23S rRNA gene of A. phagocytophilum strain USG3 (GenBank accession number AF416766), E. chaffeensis strain Arkansas (GenBank accession number AF416765), and Wolbachia pipientis (GenBank accession number U23710) were compared and aligned by using the E. coli numbering system (GenBank accession number AF278710) to look at possible mutations known to be associated with macrolide resistance (44) . The 23S rRNA sequences were aligned by using the CLUSTALW program supported by the Infobiogen website (www.infobiogen.fr).
RESULTS
Specificity, sensitivity, and reproducibility of the quantitative PCR assay. Primers used in this study were specific for the 16S rDNA of Ehrlichia and Anaplasma (35) . A 345-bp DNA fragment was consistently amplified when the PCR was carried out with DNA from all the experiments. PCRs were also negative for the negative controls (sterile water instead of DNA, uninfected host cells HL60 and DH82). We confirmed the specificity of PCR products by agarose gel electrophoresis, and DNA sequencing of PCR products always gave the expected sequence (data not shown).
Determination of growth kinetics of bacteria by real-time PCR and Diff-Quick staining. Our experiments enabled us to study and compare the growth kinetics of each bacterium by two methods. The growth curves of A. phagocytophilum as determined by Diff-Quick staining and real-time quantitative PCR are shown in Fig. 1a and b, respectively. In cultures infected with A. phagocytophilum but not treated with antibiotics, the mean percentages of infected cells were 5.7% (95% confidence interval [95% CI], 4.4 to 7%) at day 0 and 60.0% (95% CI, 54 to 66%) on day 4 (Fig. 1a) . By the real-time PCR assay, the mean numbers of DNA copies found were 298 (95% CI, 236 to 360) on day 0 and 4,702 (95% CI, 3,935 to 5,469) on day 4 (Fig. 1b) . Doubling times were estimated to be 23.5 Ϯ 4.5 h for E. chaffeensis, 24.4 Ϯ 1.4 h for A. phagocytophilum, and 26.0 Ϯ 2.0 h for E. canis. Based on the data given above, we selected day 4 to be the most appropriate time to evaluate antibiotic susceptibilities, because at this time the growth curve had reached a plateau.
MICs. In Fig. 1 , we show examples of the growth kinetics of A. phagocytophilum in cultures without antibiotics, with rifampin at 0.06 g/ml, and with cotrimoxazole at 32 g/ml. In this experiment, cotrimoxazole at 32 g/ml was not active: the geometric mean number of DNA copies at day 4 (1,754 copies) was significantly higher than that at day 0 (162 copies) (n ϭ 9 experiments [95% CI, 8.4 to 14.2]). In contrast, rifampin was active against A. phagocytophilum at 0.06 g/ml, with no growth of the organism detected by Diff-Quick staining or by real-time PCR between days 0 and 4 (no statistical difference between mean numbers of DNA copies on days 0 and 4).
The MICs we found for the 12 antibiotics we tested and those reported previously are shown in Tables 1 and 2 . The results we obtained by the two methods were very similar and never differed by more than 2 dilutions. Doxycycline and rifampin were the most active antibiotics, with very low MICs (0.03 to 0.06 g/ml). ␤-Lactam compounds, erythromycin, cotrimoxazole, and telithromycin were not active against the three bacteria, whereas MICs of thiamphenicol ranged from 1 to 4 g/ml. Gentamicin was moderately active, with MICs from 2.5 to 10 g/ml for E. chaffeensis and a MIC of 10 g/ml for E. canis. In vitro susceptibility to fluoroquinolones differed among the organisms; A. phagocytophilum was susceptible, while E. canis and E. chaffeensis were less susceptible. Sequence alignment of the 23S rRNA genes. In Fig. 2 , we present a sequence alignment of E. chaffeensis, A. phagocytophilum, W. pipientis, and E. coli 23S rDNAs. We found specific bases at positions that have been implicated in macrolide resistance in other bacteria: transitions A2058G, G2057A, A2059G, C2611T, and T754G (E. coli numbering) (44, 48) (Fig. 2) .
DISCUSSION
The experimental evaluation of antibiotic therapy of Ehrlichia and Anaplasma infections is difficult because these bacteria are fastidious intracellular bacteria, requiring cell culture systems for their propagation. Moreover, conventional phenotypic assays using staining methods cannot allow a precise quantification of bacteria because evaluation of positive cells may vary according to the operators. Brouqui and Raoult performed a blind evaluation of uninfected cells stained by DiffQuick and found a false-positive rate (cells interpreted as infected) of 3.6% (7) . The quantitative PCR we describe in this report enabled us to precisely and objectively determine the number of DNA copies of the bacteria. The specificity of the primers used in this study was previously assessed by using 19 different genera belonging to the different subgroups of Proteobacteria (35) .
The MICs we found by the two methods (Tables 1 and 2 ) were similar to those reported previously (7, 8, 23, 28, 33, 40) . Doxycycline and rifampin were the most active drugs in vitro against E. chaffeensis, E. canis, and A. phagocytophilum, and (Tables 1 and  2 ). Tetracyclines are considered to be the first-line antibiotics for treatment of ehrlichial diseases (14) . They have the advantage of being active against Borrelia burgdorferi, the agent of Lyme disease, which is transmitted by the same tick vector as A. phagocytophilum (12) . Alternatives to tetracyclines are needed for children under the age of 8 years because of the potential for tooth discoloration; for pregnant women because of possible bone toxicity in the fetus; for allergic patients; and for patients with gastric intolerance of the antibiotic. Also, although tetracyclines are effective during the acute phase of canine ehrlichiosis, chronically infected dogs do not respond to treatment with tetracyclines (22, 26) . This is probably due to a lack of bactericidal activity of these compounds. Rifampin can be used for pregnant women or children, and there are anecdotal reports of successful treatment of infections using this antibiotic (9, 14, 24, 29) .
Ampicillin, ceftriaxone, and cotrimoxazole were not active in vitro, as was previously reported (7, 8, 28) . Ehrlichiae are highly pleomorphic and are enveloped in a rippled thin outer membrane which lacks thickening of the inner or outer leaflet and shows no sign of a peptidoglycan layer or lipopolysaccharide (38) , which is the ␤-lactam target site. Recently, analysis of E. chaffeensis and A. phagocytophilum genome sequences revealed that these bacteria lack the genes for biosynthesis of lipid A and most genes for biosynthesis of peptidoglycan, both of which confer structural strength on gram-negative bacteria (30) . This situation is very similar to that of mycoplasmas, which are also naturally resistant to all ␤-lactam compounds (34) .
Our study confirms that macrolides and telithromycin (a ketolide derivative) lack antimicrobial activity against these bacteria (6, 7, 28, 33, 40) . Many cases of macrolide resistance in clinical isolates can be linked to alteration of specific nucleotides in the 23S rRNA gene within the large ribosomal subunit (44) . We report, for the first time, numerous specific nucleotides known to confer resistance to macrolides in the E. chaffeensis and A. phagocytophilum 23S rRNA genes ( Fig. 2 ): T754(G/A), G2057A, A2058G, A2059(G/C), and C2611(T/A). In addition, we found as many as 4 of these specific nucleotides occurring together, which has never been reported before. W. pipientis, a closely related organism, also possesses mutations A2058G, A2059C, C2611G, and T754A, which may explain the intrinsic resistance of this bacterium to macrolides (18) . The role of each of these mutations is not clear, and correlation between resistance to macrolides and specific nucleotide sequences in the 23S rDNA should be investigated in the future in order to better understand the molecular mechanism of resistance in this group of bacteria. Mutations at position 2058 (using the E. coli numbering system [GenBank accession number AF278710]) are the only substitutions to confer high resistance to all the macrolides (44) . Mutations at position 2059 have been found in vivo in mycobacteria, propionibacteria, Helicobacter pylori, Streptococcus pneumoniae, and Mycoplasma spp. (36, 44) . Low-level drug resistance is provided by mutations at positions 2057, 2452, and 2611 and has been described for an E. coli laboratory strain with a mutation at position 754 in hairpin 35 (48) . Mutations at position 2057 in clinical isolates have been found in erythromycin-resistant Propionibacterium spp. (42), chloramphenicoland erythromycin-resistant E. coli (44) , and a clarithromycinresistant double-mutant strain of H. pylori (44) .
We found that thiamphenicol appeared to be more active than chloramphenicol against E. canis (8) and E. chaffeensis (7) . However, Klein et al. reported 75% growth inhibition of A. phagocytophilum with chloramphenicol at 32 g/ml after 3 days (28), and Maurin et al. reported variable activity among strains (33) . In practice, chloramphenicol is not widely used because of hematological side effects and inconsistent activity (1, 11, 16, 17, 19, 21) . Both chloramphenicol and thiamphenicol inhibit protein synthesis by decreasing peptidyl transferase activity of the 70S ribosome subunit, but chloramphenicol binds to the target site with higher affinity and dramatically decreases polynuclear phagocytic function (10) . Thiamphenicol would have the advantage of being less toxic (43) , but further clinical data are needed to define the usefulness of this drug. Ehrlichia and Anaplasma are not usually susceptible to aminoglycosides. However, amikacin is the only drug that is tested often. Brouqui and Raoult reported a decrease in the number of infected cells after 9 days of incubation with gentamicin at 32 g/ml (7). Klein et al. reported inhibitory activity of gentamicin against A. phagocytophilum exposed for 3 days to 50 g/ ml, a level not achievable in human blood without severe toxicity (28) . Gentamicin MICs found in this study were 2.5 to 10 g/ml for E. chaffeensis and E. canis and 20 g/ml for A. phagocytophilum.
Fluoroquinolones are more active in vitro against A. phagocytophilum than against E. chaffeensis and E. canis (Tables 1  and 2 ). gyrA-mediated resistance has recently been found in E. canis and E. chaffeensis, and this might explain the differences in sensitivity that we found (32) .
Conclusion. Ehrlichioses and anaplasmoses are emerging infectious diseases that can cause severe disease and are of major medical concern. Clinical data on the treatment of these diseases are limited, and Ehrlichia and Anaplasma are regarded as highly resistant organisms, because only two drugs are always effective in treatment: doxycycline and rifampin. The new quantitative PCR assay that we describe proved very useful for determination of the antibiotic susceptibilities of the organisms. Because this method is very sensitive and reproducible, it could easily be standardized for quantification of the bacteria with a low possibility of contamination. Antibiotic selective forces in ticks and animals are probably minimal, but more data with regard to new isolates may be important in tracking these emerging infections and their resistance patterns. Since these bacteria are extremely fastidious, routine evaluation of antibiotic susceptibility is not possible and should not dictate therapy.
